Embecta Corp.

EMBC Nasdaq CIK: 0001872789

Company Information

Industry Surgical & Medical Instruments & Apparatus
SIC Code 3841
Entity Type operating
SEC Category Large accelerated filer
State of Incorporation DE
Business Address 300 KIMBALL DRIVE, PARSIPPANY, NJ, 07054
Mailing Address 300 KIMBALL DRIVE, PARSIPPANY, NJ, 07054
Phone 8624010000
Fiscal Year End 0930
EIN 871583942

Financial Overview

FY2025

Recent SEC Filings

Form Type Date Filed Document
SCHEDULE 13G/A Passive ownership amendment March 26, 2026 View on SEC
8-K Current report of material events March 20, 2026 View on SEC
4 Insider stock transaction report February 13, 2026 View on SEC
4 Insider stock transaction report February 13, 2026 View on SEC
4 Insider stock transaction report February 13, 2026 View on SEC
4 Insider stock transaction report February 13, 2026 View on SEC
8-K Current report of material events February 13, 2026 View on SEC
4 Insider stock transaction report February 13, 2026 View on SEC
4 Insider stock transaction report February 13, 2026 View on SEC
10-Q Quarterly financial report February 5, 2026 View on SEC

Annual Reports

10-K November 25, 2025
  • Launched a simpler insulin pen
  • Expanded into 2 new countries
View Analysis

Material Events

8-K Acquisition March 20, 2026
High Impact
  • Embecta is acquiring Owen Mumford Holdings Limited (OM) for up to £150 million (about $190 million USD).
  • The acquisition brings OM's leading medical device design, manufacturing, and the innovative Aidaptus® auto-injector technology.
View Analysis

Related Companies

Companies in the same industry (SIC: 3841)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.